Lamivudine And Zidovudine 76282-0115-05
- Manufacturer
- Exelan Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 29, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA203259
Need to source Lamivudine And Zidovudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 150 mg/1 |
| Zidovudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
76282-0115-05Selected500 TABLET, FILM COATED in 1 BOTTLE (76282-115-05)
Other packages for this product(1)
60 TABLET, FILM COATED in 1 BOTTLE (76282-115-60)